Zi Xian Eve Ngoh

Title: The Innovations of Zi Xian Eve Ngoh

Introduction

Zi Xian Eve Ngoh is a notable inventor based in Singapore, recognized for his contributions to the field of biotechnology. He has made significant strides in the development of antibodies that target glypican-3, a protein associated with various cancers. His work is pivotal in advancing therapeutic options for patients.

Latest Patents

Zi Xian Eve Ngoh holds a patent for Glypican-3 (GPC-3) antibodies. This patent describes an antibody or antigen-binding fragment that comprises a heavy chain variable region (V) sequence and a light chain variable region (V) sequence from a specific clone. The antibody is capable of specifically binding to glypican-3 (GPC-3), which is crucial for targeted cancer therapies. He has 1 patent registered under his name.

Career Highlights

Ngoh is affiliated with the Agency for Science, Technology and Research, where he conducts research and development in biotechnology. His work has been instrumental in exploring new avenues for cancer treatment, showcasing his commitment to scientific advancement.

Collaborations

Zi Xian Eve Ngoh collaborates with esteemed colleagues, including Cheng-I Wang and Bei Wang. These partnerships enhance the research efforts and contribute to the innovative projects within their field.

Conclusion

Zi Xian Eve Ngoh's contributions to biotechnology, particularly through his patent on Glypican-3 antibodies, highlight his role as a significant inventor in the scientific community. His work continues to pave the way for advancements in cancer treatment.